Evidence map›Paper›PMID 38572008›Full record

ArticleFrontiers in public health2024

Early predictors of intensive care unit admission among COVID-19 patients in Qatar.

Safae Abuyousef, Shaikha Alnaimi, Nabil E Omar, Reem Elajez, Eman Elmekaty, Eiman Abdelfattah-Arafa, Raja Barazi, Rola Ghasoub, Ala Rahhal, Fatima Hamou and 10 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. COVID-19 Vaccination in Cancer Patients: A Review Article.Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Safae AbuyousefDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Shaikha AlnaimiDepartment of Pharmacy, Hamad Bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar.
Nabil E OmarDepartment of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Reem ElajezDepartment of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Eman ElmekatyDepartment of Pharmacy, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Eiman Abdelfattah-ArafaDepartment of Pharmacy, Al-Khor Hospital, Hamad Medical Corporation, Doha, Qatar.
Raja BaraziDepartment of Pharmacy, Al Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.
Rola GhasoubDepartment of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Ala RahhalDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Fatima HamouDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Maha Al-AmriDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Ahmed KarawiaDepartment of Pharmacy, Rumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Fatima AjajDepartment of Pharmacy, Home Health Care, Hamad Medical Corporation, Doha, Qatar.
Raja AlkhawajaDepartment of Pharmacy, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Ahmed KardoushaDepartment of Pharmacy, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
Ahmed AwaisuCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Adel Abou-AliAstellas Pharma Global Development, Inc., Northbrook, IL, United States.
Mohamad KhatibDepartment of Critical Care, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Mohammed AboukamarDepartment of Infectious Disease, Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
Moza Al-HailDepartment of Pharmacy, Women's Wellness and Research Center, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: COVID-19 is associated with significant morbidity and mortality. This study aimed to explore the early predictors of intensive care unit (ICU) admission among patients with COVID-19. Methods: This was a case-control study of adult patients with confirmed COVID-19. Cases were defined as patients admitted to ICU during the period February 29-May 29, 2020. For each case enrolled, one control was matched by age and gender. Results: A total of 1,560 patients with confirmed COVID-19 were included. Each group included 780 patients with a predominant male gender (89.7%) and a median age of 49 years (interquartile range = 18). Predictors independently associated with ICU admission were cardiovascular disease (adjusted odds ratio (aOR) = 1.64, 95% confidence interval (CI): 1.16-2.32, Conclusion: Having cardiovascular disease, diabetes, obesity, lymphopenia, dyspnea, and increased AST, ferritin, and CRP were independent predictors for ICU admission in patients with COVID-19.

Indexed as

Cardiovascular DiseasesCOVID-19Diabetes MellitusLymphopeniaAdultCase-Control StudiesDyspneaFerritinsHumansIntensive Care UnitsMaleMiddle AgedObesityQatarRisk FactorsFerritinsCOVID-19critically ill patientsintensive care unitmortalitypredictorsrisk factors

Identifiers

PMID38572008
PMCPMC10987715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.